(Q36919724)

17 August 2017

1 reference

title

Etiology and natural history of diabetic retinopathy: an overview (English)

1 reference

17 August 2017

1 reference

Candis M Morello

1

1 reference

17 August 2017

publication date

1 September 2007

1 reference

American Journal of Health-System Pharmacy

17 August 2017

published in

1 reference

17 August 2017

volume

64

1 reference

17 August 2017

issue

17 Suppl 12

1 reference

17 August 2017

page(s)

S3-7

1 reference

Economic costs of diabetes in the US in 2002.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070330

Molecular understanding of hyperglycemia's adverse effects for diabetic complications

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070330

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070330

Diabetic complications. The importance of glucose control

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070330

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070330

The prevalence of diabetic retinopathy among adults in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070330

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070330

Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP070330

31 March 2020

Identifiers

DOI

10.2146/AJHP070330

1 reference

17 August 2017

1 reference